Back to Search Start Over

Zebrafish models of inflammation in hematopoietic development and disease.

Authors :
Ketharnathan S
Rajan V
Prykhozhij SV
Berman JN
Source :
Frontiers in cell and developmental biology [Front Cell Dev Biol] 2022 Jul 18; Vol. 10, pp. 955658. Date of Electronic Publication: 2022 Jul 18 (Print Publication: 2022).
Publication Year :
2022

Abstract

Zebrafish offer an excellent tool for studying the vertebrate hematopoietic system thanks to a highly conserved and rapidly developing hematopoietic program, genetic amenability, optical transparency, and experimental accessibility. Zebrafish studies have contributed to our understanding of hematopoiesis, a complex process regulated by signaling cues, inflammation being crucial among them. Hematopoietic stem cells (HSCs) are multipotent cells producing all the functional blood cells, including immune cells. HSCs respond to inflammation during infection and malignancy by proliferating and producing the blood cells in demand for a specific scenario. We first focus on how inflammation plays a crucial part in steady-state HSC development and describe the critical role of the inflammasome complex in regulating HSC expansion and balanced lineage production. Next, we review zebrafish studies of inflammatory innate immune mechanisms focusing on interferon signaling and the downstream JAK-STAT pathway. We also highlight insights gained from zebrafish models harbouring genetic perturbations in the role of inflammation in hematopoietic disorders such as bone marrow failure, myelodysplastic syndrome, and myeloid leukemia. Indeed, inflammation has been recently identified as a potential driver of clonal hematopoiesis and leukemogenesis, where cells acquire somatic mutations that provide a proliferative advantage in the presence of inflammation. Important insights in this area come from mutant zebrafish studies showing that hematopoietic differentiation can be compromised by epigenetic dysregulation and the aberrant induction of signaling pathways.<br />Competing Interests: JB is a member of the Scientific Advisory Board of Oxford Immune Algorithmics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Ketharnathan, Rajan, Prykhozhij and Berman.)

Details

Language :
English
ISSN :
2296-634X
Volume :
10
Database :
MEDLINE
Journal :
Frontiers in cell and developmental biology
Publication Type :
Academic Journal
Accession number :
35923854
Full Text :
https://doi.org/10.3389/fcell.2022.955658